US agencies have adopted stronger policies but have not always followed them.

As failures to replicate results using the CRISPR alternative stack up, a quiet scientist stands by his claims.

Iranian judiciary confirms hanging of Shahram Amiri who it claims was a spy who had given away state secrets

Ahmed H. Zewail, an Egyptian-American who won the Nobel Prize in Chemistry in 1999 for developing a revolutionary technique to observe the dance of molecules as they break apart and come together in chemical reactions, died on Tuesday. He was 70.

Ambitious bids in the US to map the brain and cure cancer have not boosted overall research funding.

New science minister promises to review controversial reforms

The American space agency, Nasa, is to make all its research available free of charge.

Your definitive guide to using social media as an academic

New evidence in the battle to control a gene-editing technology that is worth billions.

The zoo of bacteria and viruses within each lab animal may be confounding experiments.

New 2016 Top 500 world university rankings conducted by CWCU of Shanghai Jiao Tong University (Academic Ranking of World Universities).

Not just a competition but a resource that will continue to be useful now and in the future as we tackle improving reproducibility in the sciences.

Currently, there is no record of previous submission of a paper to other journals and the comments it might have received in the journey to the final publication. A paper that might have been rejected by three or four journals goes into press, and people hear about the results without any of the background scientific debate and conversation that led to this publicatio.

We present a deeper view of our 2015 financials, covering publishing and non-publishing expenses. As part of our ambition to change how science publishing works, especially among highly selective journals, we hope that being transparent about our costs will help to set a future course for research communication that is efficient and sustainable.

Chancellor Philip Hammond guarantees EU funding beyond date UK leaves the EU. British businesses and universities will have certainty over future funding and should continue to bid for competitive EU funds while the UK remains a member of the EU.

American Chemical Society to lead effort to match other disciplines

Senator Elizabeth Warren called on researchers to make public data they collect while testing drugs and medical devices on patients. Others disagree.

China has come out top in a new ranking that identifies the universities that have shown the most significant growth in the number of high-quality research publications.

Think tanks are seen as independent, but their scholars often push donors’ agendas, amplifying a culture of corporate influence in Washington.

Researchers dropped from EU grant proposal because UK inclusion would ‘compromise’ project.

Thousands of conservation and environmental biologists must now survive two rounds of peer review before getting funding from the National Science Foundation (NSF). NSF says that the two-stage review process, which it launched 4 years ago as a pilot project in two divisions within its biology directorate, has resulted in a more manageable workload and fuller consideration of the highest-quality proposals.

Controversial studies of animals containing human stem cells could be funded if they pass agency ethics review

Researcher who spent months chasing permission to republish online data sets urges others to read up on the law.

Hundreds of scientists said the research community isn’t yet ready to release data on a relatively quick turnaround.

Beate El-Chichakli and colleagues outline principles for coordinating bio-based industries to achieve many of the sustainable development goals.

The institute's board was sent home after denying Christian Bréchot, who's almost 65, a second term

Greenpeace accepts climate science. So why do they dismiss the science around GMOs?

A study on neuroscience casts doubt on established results.

The group is composed of: Cédric Villani, Elvira Fortunato, Rolf-Dieter Heuer, Moedas, Henrik Wegener, Pearl Dykstra, Janusz Bujnicki, and Julia Slingo.

Multimillion dollar initiative prioritizes drug development over discovery of new molecules.